Author

David L Kelly

Fred and Pamela Buffett Cancer Center

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Amarnath NatarajaniD· 1 shared Grinu MathewiD· 1 shared Kabhilan MohaniD· 1 shared Smitha KizhakeiD· 1 shared Sriya Sridhar· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

5 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Amarnath NatarajanORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A Multi-Kinase Inhibitor Screen Identifies mTOR Signaling as a Vulnerability in Advanced Prostate Cancer.

Sriya Sridhar, Kabhilan Mohan, Smitha Kizhake, Amarnath Natarajan, David L Kelly, Grinu Mathew

This study identifies mTOR signaling as a therapeutic target in AXL-deficient advanced prostate cancer through kinase inhibitor screening and functional analysis.

bioRxiv · Oct 14, 2026 · PreprintCancer Biology